Table 3.

Mean Scores at Baseline, Week 2, and Week 4 in Both Treatment Groups

Efficacy Evaluation Score
Parameters	Conventional Itraconazole	Super Bioavailable Itraconazole	p Value
TSS
Baseline	9.73±1.59	9.35±1.32	0.33
Day 14	4.06±1.77	3.15±1.35	0.03*
Day 28	1.58±1.90	0.65±1.09	0.03*
BSA
Baseline	2.23±0.55	1.94±0.68	0.07
Day 14	1.27±0.63	0.88±0.59	0.01*
Day 28	0.48±0.63	0.15±0.37	0.02*
IGA
Baseline	2.54±0.51	2.40±0.5	0.2
Day 14	1.30±0.53	1.05±0.27	0.03*
Day 28	0.53±0.67	0.20±0.51	0.04*

Note: *Statistically significant values.